Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03030742 · ClinicalTrials.gov registry record
Postpartum Opioid Prescribing Patterns and Patient Utilization
A clinical trial of Opioid Use and Postpartum, sponsored by Northwestern University.
- Completed
- Registry status
- 494
- Enrollment target
- 1
- Study location
NCT03030742: Completed study of Opioid Use and Postpartum, sponsored by Northwestern University.
NCT03030742 is a study of Opioid Use and Postpartum that has completed, run by Northwestern University. The registered enrollment target is 494 participants, below the 148,255-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03030742, a study of Opioid Use and Postpartum, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 494 participants
- Enrollment target
- 1
- Study location
Study Summary
This study seeks to investigate the prescribing patterns and patient utilization of opioid pain medication in the postpartum setting. Postpartum women will be surveyed prior to hospital discharge and again at 2-4 weeks postpartum in order to assess the number of opioid tablets they used (in relation to the number prescribed), pain satisfaction, and storage/disposal of any remaining opioid tablets.
Primary Outcome
Self reported number of opioid tablets used at time of postpartum survey administered 2-4 weeks postpartum
Conditions Studied
Interventions
- OTHER Survey
Study Locations (1)
Illinois
- Northwestern University - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 494 participants |
| Start Date | 2017-06-01 |
| Est. Completion | 2019-12-31 |
What the finished NCT03030742 record still lists
NCT03030742 is an observational study that tracks outcomes without assigning an intervention. The registered 494 participants enrollment target is mid-sized for trials with a published cap, below the 148,255-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower).
The record links to 4 conditions, with Opioid Use appearing as the primary indexed condition, and to 1 intervention - of which Survey is the first listed.
NCT03030742 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT03030742 about?
NCT03030742 is a clinical study titled "Postpartum Opioid Prescribing Patterns and Patient Utilization". This study seeks to investigate the prescribing patterns and patient utilization of opioid pain medication in the postpartum setting. Postpartum women will be surveyed prior to hospital discharge and again at 2-4 weeks postpartum in order to assess the number of opioid tablets they used (in relation...
What is the current status of trial NCT03030742?
This trial is currently completed. The enrollment target is 494 participants. The study started on 2017-06-01. Estimated completion is 2019-12-31.
What conditions does trial NCT03030742 study?
This clinical trial studies the following conditions: Opioid Use, Postpartum, Cesarean Delivery, Post Operative.
What interventions are being tested in trial NCT03030742?
The interventions under investigation include: Survey (OTHER).
Who is sponsoring clinical trial NCT03030742?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03030742 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03030742's enrollment target sits among peer trials
494 19th of 105 higher than 87 of 105 other Opioid Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Opioid Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression
RECRUITING · Phase 3
-
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
RECRUITING · Phase 4
-
Motivational Interviewing and Mindfulness-Oriented Recovery Enhancement
RECRUITING · Phase 3
-
Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism
RECRUITING · Phase 2
-
QL vs LAI for Palatoplasty
RECRUITING · NA
-
Opioid Use After Laparoscopic Salpingectomy
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03127267 · 495 participants · Phase 3
Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
- NCT06400472 · 495 participants · Phase 1
A Study of LY4170156 in Participants With Selected Advanced Solid Tumors
- NCT05283720 · 496 participants · Phase 2
A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma
- NCT06417775 · 496 participants · Phase 3
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI